Now a third option is available after the U.S. Food and Drug Administration last week approved Vertex Pharmaceuticals’ Suzetrigine, sold as twice-daily Journavx, a non-addictive prescription drug for ...
That’s the opinion of top Vertex Pharmaceuticals executives and several market analysts about the Boston-based company’s painkiller Journavx, which the Food and Drug Administration approved on ...
The new non-opioid drug has been approved for the treatment of severe pain, such as that following surgery or an injury.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback